Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node

Status Terminated

Clinical Trial Summary

Surgery for vulvar cancer involves removal of the central tumour as well as groin node dissection as indicated depending on the stage of tumour. Groin node dissection is associated with significant complications including lymphorrea, lymphocyst formation, wound breakdown as well as long term complications including lymphedema.

This study has been designed with each patient acting as their own control to investigate if using the PlasmaJet during surgery is associated with a reduction in the above mentioned complications.

Clinical Trial Description

Vulvar malignancy is the fourth most common malignancy of the female genital tract. Surgical excision achieves excellent local control and remains the mainstay of treatment.

Surgical excision depends on the extent of disease and may be in the form of wide local excision or radical vulvectomy. Lymphadenectomy in the form of bilateral groin node dissection (BGND) is performed for all central tumors with depth of invasion greater than 1 mm, unless there is significant comorbidity contraindicating this, but is known to cause significant postoperative morbidity. Immediate postoperative complications include breakdown and lymphocyst formation in more than 50% of cases. The PlasmaJet is a novel device that produces a jet of pure argon plasma by heating pressurized argon gas. Energy from the argon plasma transfers to tissue as light, heat, and kinetic energy.

Following ethical approval, a prospective, crossover, doubleblind, randomized, control trial to assess the PJ system, with the primary outcome being the possibility of reduction in wound breakdown and lymphocyst and lymphedema formation following BGND for vulvar cancer was opened. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04105465
Study type	Interventional
Source	Royal Surrey County Hospital NHS Foundation Trust
Contact
Status	Terminated
Phase	N/A
Start date	July 2013
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00543543` - Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)	Phase 3
Completed	`NCT02096783` - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer	N/A
Completed	`NCT01986725` - The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence	Phase 2
Completed	`NCT03158220` - Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)	Phase 3
Completed	`NCT05372016` - Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	Phase 3
Recruiting	`NCT05743517` - Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)	N/A
Recruiting	`NCT05914974` - Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Recruiting	`NCT05979610` - Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies	Phase 2
Recruiting	`NCT04708470` - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers	Phase 1/Phase 2
Active, not recruiting	`NCT04357873` - Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations	Phase 2
Completed	`NCT00551187` - A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)	Phase 2
Completed	`NCT00520598` - Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)	Phase 2
Terminated	`NCT00669422` - ChemoFx® PRO - A Post-Market Data Collection Study	N/A
Completed	`NCT03676101` - Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	Phase 1
Not yet recruiting	`NCT06039111` - Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT06127836` - Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer	N/A
Completed	`NCT04952961` - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	N/A
Completed	`NCT01806350` - Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors	N/A
Completed	`NCT00019110` - Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer	Phase 1
Recruiting	`NCT04141449` - A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation	Phase 2

Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms